Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Dementia × UE2343 × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 Dementia 1 Alzheimer Disease 1

Interventions

XENP 1595 2 Electroencephalography 2 mazdutide 1 enzalutamide 1 UE2343 1 Tomography, X-Ray Computed 1 Tomography, Emission-Computed 1 Tablets 1 Standard of Care 1 Referral and Consultation 1 Prednisone 1 Positron-Emission Tomography 1 Methotrexate 1 Methods 1 Magnetic Resonance Imaging 1 Lysine Acetyltransferase 5 1 Hormones 1 Gonadotropin-Releasing Hormone 1 Exercise 1 Ethanol 1 Drug Delivery Systems 1 Dignity Therapy 1 Decision Support Techniques 1 Aging 1 Activities of Daily Living 1 Accidental Falls 1 Abiraterone Acetate 1 7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06125951 2026-02-18

XanaMIA

Actinogen Medical

Phase 2/3 Active not recruiting

Alzheimer Disease, Dementia, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡